pharmaphorum3d
FDA clears GSK's Priorix, first new MMR vaccine in 50 years
With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...
A visit to Three Mile Island, where Constellation Energy hopes to restart a nuclear power plant
Constellation Energy is preparing to restart what's now called the Crane Clean Energy Center on Three Mile Island to supply ...
JD Supra22d
GlaxoSmithKline and Northwestern Sue Moderna for Patent Infringement in Trio of Lawsuits
On October 15, 2024, GSK filed two complaints against Moderna in the District Court for the District of Delaware, asserting that Moderna willfully infringes GSK’s mRNA patent portfolio. In Civil ...
Business Insider7d
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...
Medpage Today on MSN1d
Gabapentinoids Tied to Hip Fractures in Older Adults
Gabapentinoids -- pregabalin and gabapentin -- were tied to increased hip fracture risk in older adults. Gabapentinoids -- ...
GlaxoSmithKline Pharma Q2 results: Net profit rises 16% to Rs 252 cr
GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs 252 crore in the September quarter, aided by robust sales across segments.
devdiscourse16d
GlaxoSmithKline's Strong Quarterly Profit Growth and Special Dividend Declaration
GlaxoSmithKline Pharmaceuticals reported a notable 16% rise in consolidated net profit for the September quarter, reaching Rs 252 crore. This growth was driven by robust sales and brand performance.
GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y
Other Operating Income------Total Income From Operations: 1,010.77: 814.65: 956.99: EXPENDITURE ...
Reuters16d
India's GlaxoSmithKline Pharma posts higher Q2 profit on strong demand
Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...
Yahoo Finance10d
GlaxoSmithKline Pharmaceuticals Limited (GLAXO.BO)
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Investing2d
GlaxoSmithKline Pakistan Ltd (GLAX)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Pharmaceutical Technology1d
Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients
GSK added Ojjaara to its portfolio through the acquisition of Sierra in 2022. Credit: Magda Wygralak via Shutterstock. Health ...